An Atypical Case of Prolonged COVID-19 Infection
Connor Lewis1, Akash Gupta2, Neil K Gupta2
1Internal Medicine, Yale School of Medicine, New Haven, USA.
Insights
Immunocompromised patients with COVID-19 may experience prolonged illness. Cycle threshold values may not accurately reflect disease severity in these individuals, suggesting a need for better diagnostic tools and treatments.
Area of Science:
- Infectious Diseases
- Virology
- Immunology
Background:
- Immunocompromised individuals are at higher risk for severe and prolonged COVID-19.
- Prolonged COVID-19 infections in this population can necessitate intensive care.
- Non-Hodgkin's lymphoma survivors are a subset of immunocompromised patients.
Observation:
- A 61-year-old immunocompromised female with a history of non-Hodgkin's lymphoma presented with a prolonged COVID-19 infection.
- Despite clinical improvement, her cycle threshold (CT) values on RT-PCR tests continued to worsen.
- This patient's course was compared to other reported cases in immunocompromised populations.
Findings:
- Cycle threshold values may not reliably indicate disease severity or progression in immunocompromised COVID-19 patients.
- RT-PCR assays targeting replicative viral RNA might offer better insights into severity and infectivity.
- The patient's prolonged disease course mirrors patterns seen in other immunocompromised individuals.
Implications:
- There is a critical need for enhanced treatment protocols for COVID-19 in immunocompromised patients.
- Improved infection prevention strategies are essential for protecting this vulnerable population from SARS-CoV-2.
- Further research into diagnostic markers for prolonged COVID-19 in immunocompromised individuals is warranted.
Abstract:
Immunocompromised patients with COVID-19 can have prolonged disease courses that require escalation in care to inpatient or ICU settings. We report a case of a prolonged, active COVID-19 infection in an immunocompromised 61-year-old female with a history of non-Hodgkin's lymphoma. During her hospitalization, her cycle thresholds (CT) continued to worsen despite clinical improvement. We compared our patient's course and CTs to other reported cases in immunocompromised patients, investigating the efficacy of CTs and their use in evaluating disease progression and severity. RT-PCR tests targeting specific types of replicative viral RNA may have more utility in assessing disease severity and infectivity in immunocompromised patients. Our patient's disease course, similar to other reported cases, illustrates the need for improved treatment protocols and infection prevention for the immunocompromised population against SARS-CoV-2.
Related Concept Videos
Stages of Infection
Myocarditis II: Clinical Features and Diagnostic Tests
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Pneumonia II: Pathophysiology


